GYRE vs PVH · rev $53.5M vs P/E 24, rev $8.95B
Gyre Therapeutics Inc. (GYRE) versus PVH Corp (PVH) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
PVH Corp (PVH) is a apparel manufacturing company listed on US.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported PVH revenue for 2026-02-01 was $8.95B. Net income was $25.3M. Revenue was up 3.4% from 2025-02-02 to 2026-02-01. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
GYRE currently screens at market cap $589.9M. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
Not investment advice. Open the GYRE and PVH stock pages for the full models.
Not investment advice.